EOM Pharmaceutical Holdings (IMUC) Stock Price, News & Analysis
Company Description
EOM Pharmaceutical Holdings (OTC Link: IMUC) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $11.3M.
IMUC has gained 137.9% over the past year. Shares last traded at $0.1301.
For FY2017, EOM Pharmaceutical Holdings reported revenue of $0 with net income of -$14.3M.
This page collects what Stock Titan holds for IMUC, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
EOM Pharmaceutical Holdings (IMUC) stock last closed at $0.1301. Over the past 12 months, the stock has gained 137.9%. At a market capitalization of $11.3M, IMUC is classified as a micro-cap stock with approximately 126.5M shares outstanding.
Latest News
EOM Pharmaceutical Holdings has 4 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, covid-19, acquisition. View all IMUC news →
SEC Filings
Financial Highlights
operating income reached -$21.2M, and net income was -$14.3M. The company generated -$16.7M in operating cash flow. With a current ratio of 2.97, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in EOM Pharmaceutical Holdings (IMUC) currently stands at 40 shares, representing 0.0% of the float. Since July 2025, short interest has decreased by 48.7%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for EOM Pharmaceutical Holdings (IMUC) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
IMUC Company Profile & Sector Positioning
EOM Pharmaceutical Holdings (IMUC) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing IMUC often look at related companies in the same sector, including Sirona Biochem (SRBCF), Genflow Biosciences (GENFF), Preveceutical (PRVCF), ZEO ScientifiX (ZEOX), and Marvel Biosciences Corp (MBCOF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IMUC's relative position within its industry.